News Room

An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer April 1, 2021 ― Biopharmaceutical and medical technology companies are true pillars of

An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer and Anthony S. Cicatiello, President of the R&D Council of New Jersey March

An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer February 19, 2021 ― Medical innovation in the U.S. is at an inflection

An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer January 9, 2021 ― New Jersey has long been a national and global

HINJ salutes the work of the life sciences industry during this unprecedented pandemic. “Today’s rollout in New Jersey of the Pfizer and BioNTech vaccine for

The HealthCare Institute of New Jersey (HINJ) supports responsible ways to lower health care costs for patients that do not jeopardize the ability of life